Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America
May 06, 2024 07:01 ET
|
STELLANTIS N.V
Stellantis Pro One Achieves No. 1 Spot in Middle East & Africa Region and Strengthens Commercial Vehicle Leadership in Europe and South America Achieves No. 1 spot with a record 26% market share...
BiomX to Present at the 2024 RBC Capital Markets Global Healthcare Conference
May 06, 2024 07:00 ET
|
BiomX
CAMBRIDGE, Mass. and NESS ZIONA, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and engineered...
AMG Reports Financial and Operating Results for the First Quarter of 2024
May 06, 2024 07:00 ET
|
Affiliated Managers Group, Inc.
Company reports EPS of $4.14, Economic EPS of $5.37 in first quarter Net Income (controlling interest) of $150 million, Economic Net Income (controlling interest) of $187 millionEconomic Earnings per...
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
May 06, 2024 07:00 ET
|
Omega Therapeutics
Advanced MYCHELANGELO™ I trial dose escalation to Cohort 5; Presentation of additional monotherapy data and planned expansion into Phase 2 settings expected in mid-2024Presented new preclinical data...
Join Mobilicom’s Exclusive Live Investor Webinar and Q&A Session on May 9
May 06, 2024 07:00 ET
|
Mobilicom Limited
SHOHAM, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB), a provider of cybersecurity and robust solutions for drones and robotics, is pleased to invite investors to a...
KP Tissue Announces Filing and Mailing of the Management Proxy Materials in Connection with its 2024 Annual Meeting of Shareholders
May 06, 2024 07:00 ET
|
KP Tissue Inc.
Your vote is important no matter how many shares you own. Vote today.Shareholders who have questions or need assistance with voting should contact KP Tissue’s proxy solicitation agent and shareholder...
Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024
May 06, 2024 07:00 ET
|
Cara Therapeutics, Inc.
STAMFORD, Conn., May 06, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a development-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of...
Foghorn Therapeutics Provides First Quarter 2024 Financial and Corporate Update
May 06, 2024 07:00 ET
|
Foghorn Therapeutics, Inc.
Dose escalation in FHD-286 combination trial in AML continues to progress with clinical data expected in the second half of 2024; potential to be a first-in-class oral broad-based differentiation...
Boussard & Gavaudan Investment Management LLP: Form 8.3 -
May 06, 2024 07:00 ET
|
Boussard & Gavaudan Investment Management LLP
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY...
Verkkokauppa.com Oyj: Jesper Blomster appointed as new CFO and member of the management team in Verkkokauppa.com Oyj
May 06, 2024 07:00 ET
|
Verkkokauppa.com Oyj
Verkkokauppa.com Oyj STOCK EXCHANGE RELEASE 6 May 2024 at 2.00 p.m. EEST Jesper Blomster appointed as new CFO and member of the management team in Verkkokauppa.com Oyj MSc. (econ) Jesper...